| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | CCT018159 | GDSC1000 | pan-cancer | AAC | -0.01 | 0.8 |
| mRNA | FH535 | GDSC1000 | pan-cancer | AAC | 0.01 | 0.8 |
| mRNA | Oxaliplatin | CTRPv2 | pan-cancer | AAC | -0.01 | 0.8 |
| mRNA | CIL56 | CTRPv2 | pan-cancer | AAC | -0.014 | 0.8 |
| mRNA | Irinotecan | gCSI | pan-cancer | AAC | -0.017 | 0.8 |
| mRNA | 17-AAG | FIMM | pan-cancer | AAC | -0.055 | 0.8 |
| mRNA | WZ-1-84 | GDSC1000 | pan-cancer | AAC | 0.015 | 0.8 |
| mRNA | BRD-K55116708 | CTRPv2 | pan-cancer | AAC | 0.011 | 0.8 |
| mRNA | Vinblastine | GDSC1000 | pan-cancer | AAC | 0.0099 | 0.8 |
| mRNA | necrostatin-1 | CTRPv2 | pan-cancer | AAC | 0.011 | 0.8 |